Business Sandoz sues Amgen in U.S. antitrust case over arthritis drugBy Gazet InternationalApril 14, 20250 Sandoz, a Swiss generic drug manufacturer, has filed an antitrust lawsuit in the U.S. They are accusing Amgen of illegally maintaining its market dominance of Enbrel… Read More